Mulsun Biotech Overview
- Year Founded
-
2015
- Status
-
IPO Registration
- Employees
-
974
- Latest Deal Type
-
IPO
- (Announced)
- Investors
-
12
Mulsun Biotech General Information
Description
Developer of factory-based silkworm rearing technology and silk protein applications designed to modernize traditional sericulture through biotechnology and automation. The company integrates artificial feed formulas, intelligent equipment, and environmental control systems to produce fresh cocoons, dried cocoons, and silk floss, enabling the year-round stable production of high-quality silk materials and the development of silk protein for food preservation and cosmetics.
Contact Information
Website
www.lxm3s.comCorporate Office
- No. 788, Yijing Road, Sanjiang Street
- Shengzhou
- Shaoxing, Zhejiang 312400
- China
Corporate Office
- No. 788, Yijing Road, Sanjiang Street
- Shengzhou
- Shaoxing, Zhejiang 312400
- China
Mulsun Biotech Timeline
Mulsun Biotech Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 14. IPO | 29-Jun-2026 | Announced | Profitable | |||
| 13. IPO | 22-Jan-2026 | Completed | Profitable | |||
| 12. Secondary Transaction - Private | 23-Oct-2025 | Completed | Profitable | |||
| 11. Secondary Transaction - Private | 08-Sep-2025 | Completed | Profitable | |||
| 10. Later Stage VC | 07-Aug-2025 | Completed | Profitable | |||
| 9. Later Stage VC | 01-Apr-2024 | Completed | Profitable | |||
| 8. Later Stage VC (Series A2) | 22-Dec-2023 | Completed | Profitable | |||
| 7. Later Stage VC (Series A2) | 15-Dec-2023 | Completed | Profitable | |||
| 6. Later Stage VC (Series A1) | 28-Jun-2023 | $17.4M | $51.5M | Completed | Profitable | |
| 5. Secondary Transaction - Private | 24-May-2023 | $23M | $34.2M | Completed | Profitable |
Mulsun Biotech Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Ordinary | ||||||||
| Ordinary | ||||||||
| Ordinary | ||||||||
| Ordinary | ||||||||
| Ordinary | 8,183,300 | $1.72 | $1.72 | 1x | $1.72 | 5.41% | ||
| Ordinary | 4,484,300 | $3.85 | $3.85 | 1x | $3.85 | 2.96% |
Mulsun Biotech Patents
Mulsun Biotech Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2026199424-A1 | Composite silk fiber containing spider silk protein and preparation method therefor | Pending | 28-Mar-2025 |
Mulsun Biotech Signals
Mulsun Biotech Investors (12)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Moutai (Guizhou) Private Equity Fund Management | Growth/Expansion | Minority | ||
| SDIC Innovation Industry Fund Management | Government | Minority | ||
| China Merchants Capital | Asset Manager | Minority | ||
| Youngor Group Company | Corporation | Minority | ||
| Hangzhou Shengchuang Jiyue Private Equity Fund Management | Growth/Expansion | Minority |
Mulsun Biotech FAQs
-
When was Mulsun Biotech founded?
Mulsun Biotech was founded in 2015.
-
Where is Mulsun Biotech headquartered?
Mulsun Biotech is headquartered in Shaoxing, China.
-
What is the size of Mulsun Biotech?
Mulsun Biotech has 974 total employees.
-
What industry is Mulsun Biotech in?
Mulsun Biotech’s primary industry is Animal Textiles.
-
Is Mulsun Biotech a private or public company?
Mulsun Biotech is a Private company.
-
What is Mulsun Biotech’s current revenue?
The current revenue for Mulsun Biotech is .
-
How much funding has Mulsun Biotech raised over time?
Mulsun Biotech has raised $112M.
-
Who are Mulsun Biotech’s investors?
Moutai (Guizhou) Private Equity Fund Management, SDIC Innovation Industry Fund Management, China Merchants Capital, Youngor Group Company, and Hangzhou Shengchuang Jiyue Private Equity Fund Management are 5 of 12 investors who have invested in Mulsun Biotech.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process